MSB

11.0%

$2.83

MESOBLAST LIMITED

Market Cap $3.245B Add to my watchlist

Healthcare Biotechnology

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) receives Indonesian approval for Phase 3 diabetic foot infection trial.

Latest Threads

Tag

Subject

MSB

Cell Therapy News/Articles

308 309 310

12:23

18K

7.3M

12:23

Last post Wilba32

18K

7.3M

MSB

Valuing Mesoblast based on revenue

2 3 4

12:18

222

102K

12:18

Last post imback

222

102K

MSB

banter and General Discussion

249 250 251

11:59

15K

4.9M

11:59

Last post Treed

15K

4.9M

MSB

negative

11:46

589

11:46

Last post AnotherOneWon

589

MSB

Ann: Becoming a substantial holder

11:42

21K

11:42

Last post AnotherOneWon

21K

MSB

Ann: REVASCOR Improves Survival & Reduces Major Morbidity

2 3

10:00

146

65K

10:00

Last post Hawk70

146

65K

MSB

Ann: FDA Approves Mesoblast Ryoncil

8 9 10

28/12/24

559

208K

28/12/24

Last post gavint66

559

208K

MSB

MESO Nasdaq update

106 107 108

28/12/24

6.4K

3.2M

28/12/24

Last post Kerebrad

6.4K

3.2M

See All Discussions

Timeline

Becoming a substantial holder
27 Dec 08:28	Share

Becoming a substantial holder
24 Dec 08:17	Share

Appendix 3Y for Eric Rose
20 Dec 17:21	Share

Application for quotation of securities - MSB
20 Dec 17:08	Share

Cleansing Notice
20 Dec 16:58	Share

Mesoblast Webcast
19 Dec 11:56	Share

FDA Approves Mesoblast Ryoncil
19 Dec 09:58	Share

Mesoblast to be Added to Nasdaq Biotechnology Index
18 Dec 13:57	Share

Ceasing to be a substantial holder
18 Dec 08:16	Share

Change in substantial holding
16 Dec 08:30	Share

Material Announcement
05 Dec 11:01	Share

Pause in Trade
05 Dec 10:00	Share

FDA Grants Mesoblast RMAT Designation
05 Dec 09:59	Share

REVASCOR Improves Survival & Reduces Major Morbidity
03 Dec 09:46	Share

Becoming a substantial holder
21 Nov 08:18	Share

Results of Meeting
15 Nov 17:17	Share

Final Director's Interest Notice
15 Nov 17:11	Share

CEO Presentation to 2024 Annual General Meeting
15 Nov 11:51	Share

Mesoblast Chair Message to 2024 AGM
15 Nov 11:47	Share

Response to ASX Price Query
14 Nov 15:42	Share

Notification regarding unquoted securities - MSB
12 Nov 20:07	Share

Warrant Prospectus Related to Convertible Note Agreement
07 Nov 19:15	Share

Ceasing to be a substantial holder
05 Nov 08:16	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Oct 09:44	Share

Annual Report to Shareholders
17 Oct 13:29	Share

Notice of Annual General Meeting and Proxy Form
17 Oct 13:17	Share

Appendix 4G and Corporate Governance Statement
17 Oct 13:07	Share

Notification of cessation of securities - MSB
11 Oct 17:44	Share

Notification regarding unquoted securities - MSB
11 Oct 17:44	Share

Change in substantial holding
10 Oct 13:34	Share

View More

(20min delay)
Last $2.83		Change 0.280(11.0%)		Mkt cap ! $3.245B

Open	High	Low	Value	Volume
$2.74	$2.84	$2.68	$48.39M	17.44M

Buyers (Bids)

No.	Vol.	Price($)
11	212409	$2.80

Sellers (Offers)

Price($)	Vol.	No.
$2.83	9068	2

View Market Depth

No.	Vol.	Price($)
4	40350	2.800
3	9194	2.780
2	10320	2.770
7	44921	2.760
3	39499	2.750

Price($)	Vol.	No.
2.830	4844	1
2.840	68300	5
2.850	30302	6
2.880	18000	1
2.890	16000	3

Last trade - 16.10pm 27/12/2024 (20 minute delay)

MSB (ASX) Chart

MESOBLAST LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Mesoblast (ASX:MSB) flags strengthened heart function in latest trial results

28 Feb 2023 10:07 (AEDT)

Latest Articles

Cashed up & ready to go: Mesoblast forges funding deal with top shareholder

Mesoblast (ASX:MSB) is trading up more than 1.75% after striking a funding deal with its largest shareholder Gregory George for AUD$72.7 million in convertible notes.

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Mesoblast shares fell -4.45% in the first hour of trades on Tuesday as the company announced it has to resubmit an application to the FDA.

Mesoblast (ASX:MSB) completes $97M funding round heading into Q2

Mesoblast (ASX:MSB) has completed its pro-rata accelerated non-renounceable entitlement offer, launched on December 4, 2023.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News